{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:55:08Z","timestamp":1791294908936,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002960","name":"V\u00e4sterbotten L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["Financial support was provided through a regional agreement between Ume\u00e5 University and Region V\u00e4sterbotten (ALF)."],"award-info":[{"award-number":["Financial support was provided through a regional agreement between Ume\u00e5 University and Region V\u00e4sterbotten (ALF)."]}],"id":[{"id":"10.13039\/501100002960","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stiftelsen Arne och Kerstin Sandstr\u00f6ms forskningsfond f\u00f6r reumatologisk forskning","award":["FS.216186823"],"award-info":[{"award-number":["FS.216186823"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Autoimmune processes in rheumatoid arthritis (RA) begin years before clinical symptom onset. This study aimed to analyse inflammation-related proteins in individuals during the pre-symptomatic phase, in relation to healthy controls and patients with early RA, and their relationship to seroconversion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Plasma samples collected prior to symptom onset from individuals who later developed RA (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009419), healthy population controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200949), and patients with early RA at diagnosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200968) were obtained from a biobank. All samples were analysed for 92 inflammation-related proteins using a proximity extension assay and for anti-CCP2 antibodies and rheumatoid factor. After quality control 77 proteins remained. To identify differentially expressed proteins and enriched pathways, statistical analyses including logistic regression, generalized additive models, and network enrichment analysis was applied.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four proteins (MMP10, IL6, CCL19, and IL10RB) showed a higher concentration in pre-symptomatic individuals compared to controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Twelve proteins were associated with seropositivity in the pre-symptomatic phase and network enrichment analysis of these revealed associated pathways related to the complement system and cytokine activity. Three proteins (CXCL10, CCL7, and CDCP1) were consistently associated with seroconversion and showed increasing trends approaching symptom onset in individuals who seroconverted, but not in individuals who remained seronegative. Proteins associated with early seroconversion were associated with T-cell activity, whereas many of the proteins associated with late seroconversion were associated with bone remodelling, mineral metabolism, and collagen degradation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Proteomic alterations are detectable years before RA onset and linked to autoantibody development. Seroconverters differ from those who remain seronegative even in the pre-symptomatic period, supporting the notion that seropositive and seronegative RA represent biologically distinct entities from the earliest stages of the pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-026-03917-4","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:45:57Z","timestamp":1791290757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal dynamics of inflammatory proteins in the pre-symptomatic phase of rheumatoid arthritis related to seroconversion"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1704-7493","authenticated-orcid":false,"given":"Anton","family":"Ahlsved","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1524-0851","authenticated-orcid":false,"given":"Anders","family":"Lundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5025-6539","authenticated-orcid":false,"given":"Kristina","family":"Lejon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-3863","authenticated-orcid":false,"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-3488","authenticated-orcid":false,"given":"Mikael","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"10416","key":"3917_CR1","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis. Lancet. 2023;402(10416):2019\u201333.","journal-title":"Lancet"},{"issue":"5","key":"3917_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3899\/jrheum.200367","volume":"48","author":"KB Almutairi","year":"2021","unstructured":"Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA. The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies. J Rheumatol. 2021;48(5):669\u201376.","journal-title":"J Rheumatol"},{"issue":"11","key":"3917_CR3","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.24827","volume":"61","author":"R Aggarwal","year":"2009","unstructured":"Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum. 2009;61(11):1472\u201383.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3917_CR4","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741\u20139.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3917_CR5","first-page":"1282","volume":"18","author":"K Aho","year":"1991","unstructured":"Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol. 1991;18(9):1282\u20134.","journal-title":"J Rheumatol"},{"issue":"4","key":"3917_CR6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/art.37835","volume":"65","author":"M Brink","year":"2013","unstructured":"Brink M, Hansson M, Mathsson L, Jakobsson PJ, Holmdahl R, Hallmans G, Stenlund H, Ronnelid J, Klareskog L, Rantapaa-Dahlqvist S. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum. 2013;65(4):899\u2013910.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3917_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/art.27186","volume":"62","author":"H Kokkonen","year":"2010","unstructured":"Kokkonen H, S\u00f6derstr\u00f6m I, Rockl\u00f6v J, Hallmans G, Lejon K, Rantap\u00e4\u00e4 Dahlqvist S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 2010;62(2):383\u201391.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3917_CR8","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1002\/art.27638","volume":"62","author":"KD Deane","year":"2010","unstructured":"Deane KD, O\u2019Donnell CI, Hueber W, Majka DS, Lazar AA, Derber LA, Gilliland WR, Edison JD, Norris JM, Robinson WH, et al. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum. 2010;62(11):3161\u201372.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3917_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/art.43175","volume":"77","author":"S Rachid Zaim","year":"2025","unstructured":"Rachid Zaim S, Savage AK, Gillespie MA, Castillo JD, Bennett C, Torgerson TR, Becker LA, Mahler M, Moss L, Feser ML, et al. Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development. Arthritis Rheumatol. 2025;77(9):1166\u201378.","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"3917_CR10","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1136\/ard.2009.124537","volume":"69","author":"D van der Woude","year":"2010","unstructured":"van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, Drijfhout JW, Huizinga TW, Toes RE, Pruijn GJ. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis. 2010;69(8):1554\u201361.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3917_CR11","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","volume":"7","author":"J Sokolove","year":"2012","unstructured":"Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, Edison JD, Gilliland WR, Tibshirani RJ, Norris JM, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE. 2012;7(5):e35296.","journal-title":"PLoS ONE"},{"key":"3917_CR12","doi-asserted-by":"publisher","unstructured":"Heutz JW, Toes REM, van der Helm-van Mil AHM. Time sequence of autoimmune processes in the trajectory to rheumatoid arthritis development: what do we know? RMD Open 2025;11(2). https:\/\/doi.org\/10.1136\/rmdopen-2024-005377.","DOI":"10.1136\/rmdopen-2024-005377"},{"issue":"9","key":"3917_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/ard.62.9.835","volume":"62","author":"P Stolt","year":"2003","unstructured":"Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, Alfredsson L, group Es. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis. 2003;62(9):835\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3917_CR14","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1002\/art.20553","volume":"50","author":"L Padyukov","year":"2004","unstructured":"Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004;50(10):3085\u201392.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3917_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38\u201346.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"3917_CR16","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741\u20139.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3917_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3917_CR18","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, Eriksson A, Rennel Dickens E, Ohlsson S, Edfeldt G, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9(4):e95192.","journal-title":"PLoS ONE"},{"key":"3917_CR19","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2013","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013."},{"issue":"1","key":"3917_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker BM, Walker SC. Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw. 2015;67(1):1\u201348.","journal-title":"J Stat Softw"},{"issue":"1","key":"3917_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J Royal Stat Soc Ser B-Statistical Methodol. 1995;57(1):289\u2013300.","journal-title":"J Royal Stat Soc Ser B-Statistical Methodol"},{"key":"3917_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1471-2105-13-226","volume":"13","author":"A Alexeyenko","year":"2012","unstructured":"Alexeyenko A, Lee W, Pernemalm M, Guegan J, Dessen P, Lazar V, Lehtio J, Pawitan Y. Network enrichment analysis: extension of gene-set enrichment analysis to gene networks. BMC Bioinformatics. 2012;13:226.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"3917_CR23","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"3917_CR24","doi-asserted-by":"publisher","first-page":"D685","DOI":"10.1093\/nar\/gkq1039","volume":"39","author":"EG Cerami","year":"2011","unstructured":"Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, Anwar N, Schultz N, Bader GD, Sander C. Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res. 2011;39(Database issue):D685\u2013690.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3917_CR25","first-page":"D498","volume":"48","author":"B Jassal","year":"2020","unstructured":"Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, Sidiropoulos K, Cook J, Gillespie M, Haw R, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020;48(D1):D498\u2013503.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3917_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/152791601750294344","volume":"2","author":"D Nishimura","year":"2001","unstructured":"Nishimura D. BioCarta. Biotech Softw Internet Report: Comput Softw J Scient. 2001;2(3):117\u201320.","journal-title":"Biotech Softw Internet Report: Comput Softw J Scient"},{"issue":"1","key":"3917_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13075-019-2066-9","volume":"21","author":"M Brink","year":"2019","unstructured":"Brink M, Lundquist A, Alexeyenko A, Lejon K, Rantapaa-Dahlqvist S. Protein profiling and network enrichment analysis in individuals before and after the onset of rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):288.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3917_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13075-016-0995-0","volume":"18","author":"BK Han","year":"2016","unstructured":"Han BK, Kuzin I, Gaughan JP, Olsen NJ, Bottaro A. Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study. Arthritis Res Ther. 2016;18(1):93.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3917_CR29","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/art.23372","volume":"58","author":"HB Kwak","year":"2008","unstructured":"Kwak HB, Ha H, Kim HN, Lee JH, Kim HS, Lee S, Kim HM, Kim JY, Kim HH, Song YW, et al. Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum. 2008;58(5):1332\u201342.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3917_CR30","doi-asserted-by":"publisher","first-page":"112177","DOI":"10.1016\/j.isci.2025.112177","volume":"28","author":"J Chen","year":"2025","unstructured":"Chen J, Shi S, Li X, Gao F, Zhu X, Feng R, Hu K, Li Y, Chen S, Zhang R, et al. CCL7 promotes macrophage polarization and synovitis to exacerbate rheumatoid arthritis. iScience. 2025;28(4):112177.","journal-title":"iScience"},{"issue":"12","key":"3917_CR31","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.4049\/jimmunol.2001406","volume":"206","author":"Y Lun","year":"2021","unstructured":"Lun Y, Borjini N, Miura NN, Ohno N, Singer NG, Lin F. CDCP1 on Dendritic Cells Contributes to the Development of a Model of Kawasaki Disease. J Immunol. 2021;206(12):2819\u201327.","journal-title":"J Immunol"},{"issue":"33","key":"3917_CR32","doi-asserted-by":"publisher","first-page":"E6912","DOI":"10.1073\/pnas.1704008114","volume":"114","author":"G Enyindah-Asonye","year":"2017","unstructured":"Enyindah-Asonye G, Li Y, Ruth JH, Spassov DS, Hebron KE, Zijlstra A, Moasser MM, Wang B, Singer NG, Cui H, et al. CD318 is a ligand for CD6. Proc Natl Acad Sci U S A. 2017;114(33):E6912\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3917_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1046\/j.1365-3083.2003.01214.x","volume":"57","author":"KR Shadidi","year":"2003","unstructured":"Shadidi KR, Aarvak T, Henriksen JE, Natvig JB, Thompson KM. The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissue. Scand J Immunol. 2003;57(2):192\u20138.","journal-title":"Scand J Immunol"},{"key":"3917_CR34","doi-asserted-by":"publisher","first-page":"1100869","DOI":"10.3389\/fimmu.2023.1100869","volume":"14","author":"MA Murayama","year":"2023","unstructured":"Murayama MA, Shimizu J, Miyabe C, Yudo K, Miyabe Y. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis. Front Immunol. 2023;14:1100869.","journal-title":"Front Immunol"},{"issue":"5","key":"3917_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/JLB.2MR1119-224R","volume":"107","author":"K Luu","year":"2020","unstructured":"Luu K, Shao Z, Schwarz H. The relevance of soluble CD137 in the regulation of immune responses and for immunotherapeutic intervention. J Leukoc Biol. 2020;107(5):731\u20138.","journal-title":"J Leukoc Biol"},{"issue":"11","key":"3917_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrendo.2009.196","volume":"5","author":"MS Razzaque","year":"2009","unstructured":"Razzaque MS. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol. 2009;5(11):611\u20139.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"3917_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89(2):309\u201319.","journal-title":"Cell"},{"issue":"4","key":"3917_CR38","first-page":"222","volume":"63","author":"O Mounir","year":"2025","unstructured":"Mounir O, Sedky A, Mohafez OM, Elsayed SA. Cystatin D as a biomarker for rheumatoid arthritis: relation to disease activity and joint damage. Reumatologia. 2025;63(4):222\u20138.","journal-title":"Reumatologia"},{"issue":"11","key":"3917_CR39","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.4049\/jimmunol.2101170","volume":"208","author":"NK Banda","year":"2022","unstructured":"Banda NK, Deane KD, Bemis EA, Strickland C, Seifert J, Jordan K, Goldman K, Morgan BP, Moreland LW, Lewis MJ, et al. Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features. J Immunol. 2022;208(11):2482\u201396.","journal-title":"J Immunol"},{"key":"3917_CR40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.molimm.2019.05.012","volume":"112","author":"EA Bemis","year":"2019","unstructured":"Bemis EA, Norris JM, Seifert J, Frazer-Abel A, Okamoto Y, Feser ML, Demoruelle MK, Deane KD, Banda NK, Holers VM. Complement and its environmental determinants in the progression of human rheumatoid arthritis. Mol Immunol. 2019;112:256\u201365.","journal-title":"Mol Immunol"},{"issue":"2","key":"3917_CR41","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/art.27186","volume":"62","author":"H Kokkonen","year":"2010","unstructured":"Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 2010;62(2):383\u201391.","journal-title":"Arthritis Rheum"},{"key":"3917_CR42","doi-asserted-by":"publisher","unstructured":"Pandolfi F, Franza L, Carusi V, Altamura S, Andriollo G, Nucera E. Interleukin-6 in rheumatoid arthritis. Int J Mol Sci. 2020;21(15):5238. https:\/\/doi.org\/10.3390\/ijms21155238.","DOI":"10.3390\/ijms21155238"},{"issue":"11","key":"3917_CR43","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1093\/rheumatology\/keae146","volume":"63","author":"A C\u00eerciumaru","year":"2024","unstructured":"C\u00eerciumaru A, Kisten Y, Hansson M, Mathsson-Alm L, Joshua V, W\u00e4h\u00e4maa H, Loberg Haarhaus M, Lindqvist J, Padyukov L, Catrina SB, et al. Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis-a prospective cohort study. Rheumatology (Oxford). 2024;63(11):3164\u201371.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"3917_CR44","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1002\/art.22167","volume":"54","author":"HE Barksby","year":"2006","unstructured":"Barksby HE, Milner JM, Patterson AM, Peake NJ, Hui W, Robson T, Lakey R, Middleton J, Cawston TE, Richards CD, et al. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum. 2006;54(10):3244\u201353.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03917-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03917-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03917-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:05:05Z","timestamp":1791291905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03917-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3917"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03917-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients included in the cohort have given informed written consent to participate. The cohort was approved by the local ethical committee in Ume\u00e5 (2013-247-31) and was in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"178"}}